spirogermanium has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alavi, JB; Kirkwood, R; Marsh, JC; Schoenfeld, D; Skeel, RT; Tsung, L | 1 |
| Balcerzak, S; Crowley, J; Goodwin, JW; Hacker, D; Slavik, M; Tranum, B; Vance, R | 1 |
1 trial(s) available for spirogermanium and Glial Cell Tumors
| Article | Year |
|---|---|
Phase II trial of spirogermanium and vindesine in malignant glioma.
Topics: Adult; Aged; Cerebellar Neoplasms; Drug Administration Schedule; Drug Evaluation; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Random Allocation; Spiro Compounds; Vindesine | 1989 |
1 other study(ies) available for spirogermanium and Glial Cell Tumors
| Article | Year |
|---|---|
Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study.
Topics: Adult; Aged; Cerebral Hemorrhage; Chemical and Drug Induced Liver Injury; Drug Evaluation; Female; Germanium; Glioma; Humans; Male; Middle Aged; Nervous System Neoplasms; Organometallic Compounds; Spiro Compounds | 1987 |